Your fact-checks will appear here
Ivermectin is being tested in cancer patients, specifically in a Phase I/II study for metastatic triple-negative breast cancer.
Preclinical work identifies strongest anticancer signals for ivermectin in breast cancer, hematologic malignancies (notably leukemia), hepatocellular carcinoma, and several drug-resistant solid tumor ...
A single actively registered clinical trial testing has been identified: a Phase I/II study (NCT05318469) combining oral ivermectin with anti‑PD‑1 immune checkpoint therapy for (mTNBC), and its primar...
There is evidence of a small number of early‑phase clinical trials testing ivermectin in cancer patients, but they are limited in number, mostly based in the United States, and focused on combination ...